Panhematin Alternatives Compared
Panhematin (hemin) | Givlaari (givosiran) | Chlorpromazine |
|
---|
Panhematin (hemin) | Givlaari (givosiran) | Chlorpromazine |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Porphyria. Panhematin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Porphyria. Givlaari may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hiccups, Light Sedation, Mania, Nausea/Vomiting, Opiate Withdrawal, Porphyria, Psychosis, Schizophrenia, Tetanus. Chlorpromazine may also be used for purposes not listed in this... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
More about Panhematin (hemin) | More about Givlaari (givosiran) | More about Chlorpromazine | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Panhematin has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
Chlorpromazine has an average rating of 7.0 out of 10 from a total of 70 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Panhematin side effects |
View all Givlaari side effects |
View all Chlorpromazine side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Givlaari prices |
View all Chlorpromazine prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
N/A |
6 hours |
31 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 96 drugs are known to interact with Panhematin:
|
A total of 242 drugs are known to interact with Givlaari:
|
A total of 732 drugs are known to interact with Chlorpromazine:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
November 20, 2019 |
November 20, 1957 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.